Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus.

AUTOR(ES)

Dutka-Malen, S

RESUMO

Enterococcus gallinarum BM4231 and Enterococcus casseliflavus BM4232, isolated from the feces of a patient under oral therapy with vancomycin, were resistant to high levels of vancomycin (MICs of > 256 micrograms/ml) and teicoplanin (MICs of 128 and 64 micrograms/ml, respectively). This phenotype is new for these bacterial species that are naturally resistant to low levels of vancomycin and appears to be due to in vivo acquisition of plasmid pIP218 carrying the vanA gene cluster.

Documentos Relacionados

• Cloning and heterospecific expression of the resistance determinant vanA encoding high-level resistance to glycopeptides in Enterococcus faecium BM4147.
• Plasmid-borne high-level resistance to gentamicin in Enterococcus hirae, Enterococcus avium, and Enterococcus raffinosus.
• High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium.
• High-level penicillin resistance and penicillin-gentamicin synergy in Enterococcus faecium.
• Factors influencing determination of high-level aminoglycoside resistance in Enterococcus faecalis.